HITAP in collaboration with the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) is hosting a health technology assessment (HTA) workshop on 3-5 October 2019.In this workshop, the participants will learn:What is HTA?How can the value for money of a health intervention be

We are pleased to announce that the Call for Pre-conference Sessions is open and all HTAsiaLink members are invited to propose hosting pre-conference sessions at the 10th HTAsiaLink annual conference. Members can also host the sessions together with collaborators such as HTAsialink MoU partners or y

Congratulations! – For those we are selected to present abstracts and pre-conference session proposal at the 10th HTAsiaLink Annual Conference which will be held at the Royal Cliff Grand Hotel, Pattaya, Thailand on 30 November to 2 December 2022. We appreciate All HTAsialink members who have joined

Shiela is an Associate at the HITAP International Unit. She holds a doctoral degree in Microbiology and currently leads antimicrobial resistance (AMR)-related projects at HITAP, in collaboration with international partners such as the University of Oxford, City St George’s University of London, and global organizations including the World Health Or

68139067PI029L0E-cigarette,E-learning,educational games,Health Literacy,primary school children

68305067HI027L0Research capacity building,health technology assessment,policy decision making,multidisciplinary research network,international collaboration

In 2015, a HITAP International Unit (HIU) survey identified the major challenges (both contextual and technical) to the conduct of rigorous economic evaluations for policymakers’ use in healthcare decision making. • From this study, HITAP created an online platform called the Guide to health Econ

Colorectal cancer is the third most common cancer in Indonesia with approximately 28,000 patients diagnosed each year. Without population-based screening, patients are often treated when they reach the advanced stage. Bevacizumab, a newly available high-cost treatment for metastatic colorectal ca